DMAC vs MRVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

DMAC

28.9
AI Score
VS
MRVI Wins

MRVI

44.4
AI Score

Investment Advisor Scores

DMAC

29score
Recommendation
AVOID NEW MONEY

MRVI

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DMAC MRVI Winner
Forward P/E 0 370.3704 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 8.5% MRVI
Earnings Growth 0.0% -32.7% DMAC
Tradestie Score 28.9/100 44.4/100 MRVI
Profit Margin 0.0% -37.1% DMAC
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MRVI

Relative Price Performance (Last 90 Days)

DMAC 1M: +28.4% · 3M: +5.4% MRVI 1M: +15.6% · 3M: +43.9%

Current Technical Phase

DMAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 72.6 · Price: $8.42

MRVI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 69

RSI (14): 68.7 · Price: $8.52

Fundamentals Snapshot

Metric DMAC MRVI
Market Cap — —
Forward P/E -10.4 -86.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin — 0.4%
Operating Margin 0.0% -0.3%
EPS -0.72 -0.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.